CRISPR Leadership Monday, October 19, 2026 +0.20 Positive

APP New CFO Andrew J. Silver Hired by CRISPR Therapeutics

CRISPR Therapeutics AG announced the hiring of Andrew J. Silver as its Chief Financial Officer. This leadership change is the primary market-relevant event from the filing.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed